-
1
المؤلفون: Shany Guly Gofrit, Pikman R, Shaye Kivity, Yair Levy, Joab Chapman, Yehuda Shoenfeld, Maria-Teresa Arango, Yonath H
المصدر: Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosarioمصطلحات موضوعية: Brain antigen, 0301 basic medicine, Unclassified drug, Mouse, N methyl dextro aspartic acid receptor antibody, Apoptosis, Pathogenesis, Disease, Bioinformatics, Neuroendocrine system, Animals, Genetically Modified, Dietary supplement, Mice, Autoantibody, 0302 clinical medicine, Pathology, Lupus vasculitis, Medicine, Biological therapy, animal, Priority journal, P 140 peptide, Systemic lupus erythematosus, Vaccination, Lupus Vasculitis, Central Nervous System, genetically modified, Cardiolipin antibody, Animal models, Neuropsychiatric systemic lupus erythematosus, Transgenic animal, Blood brain barrier, N methyl dextro aspartic acid receptor nr2 antibody, Cytokines, Complement inhibitor, Human, Disease onset, medicine.drug_class, Complement, Genetic predisposition to disease, Lupus, Neuropsychiatric, Murphy roths large lymphoproliferative mouse, Disease models, Monoclonal antibody, Article, Intercellular adhesion molecule 1 antibody, Brain metabolism, 03 medical and health sciences, Animal model, Rheumatology, Immunoglobulin, Genetic susceptibility, Genetics, Animals, Humans, Genetic Predisposition to Disease, Cyclophosphamide, Cytokine, Fisle 412 peptide, Autoantibodies, Immune mechanisms, Brain vasculitis, Disease model, business.industry, Mechanism (biology), Crry ig, Genetic predisposition, Targeted biological medication, Peptide fragment, Immunoregulation, Mental disease, Nonhuman, central nervous system, medicine.disease, Belimumab, Disease Models, Animal, Metabolism, 030104 developmental biology, Ribosomal p antibody, Nzbxnzw f1 mouse, Molecular targets, Hcdr1 peptide, Vitamin d, business, Cell phagocytosis, 030217 neurology & neurosurgery
وصف الملف: application/pdf
-
2Review
المساهمون: DUKE-NUS MEDICAL SCHOOL
المصدر: Unpaywall 20201031
مصطلحات موضوعية: adalimumab, alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid, CD18 antibody, CD18 antigen, endothelial leukocyte adhesion molecule 1, endothelial leukocyte adhesion molecule 1 antibody, enlimomab, Fas ligand, glutamate receptor antagonist, infliximab, intercellular adhesion molecule 1, intercellular adhesion molecule 1 antibody, interleukin 8, interleukin 8 antibody, L selectin, l selectin antibody, monoclonal antibody, myelin associated glycoprotein, n methyl dextro aspartic acid receptor, neutralizing antibody, Nogo 66 receptor, Nogo A antibody, oligodendrocyte myelin glycoprotein, PADGEM protein, protein antibody, protein Nogo A, recombinant plasminogen activator, tissue plasminogen activator, unclassified drug, active immunization
Relation: Yu, C.Y, Ng, G, Liao, P (2013). Therapeutic Antibodies in Stroke. Translational Stroke Research 4 (5) : 477-483. ScholarBank@NUS Repository. https://doi.org/10.1007/s12975-013-0281-2; https://scholarbank.nus.edu.sg/handle/10635/181806
-
3Academic Journal
المؤلفون: Correale, J.
مصطلحات موضوعية: Autoimmunity, Immunology, Lymphocytes, Multiple sclerosis, Pregnancy, alpha interferon, antibody, beta1 integrin, CD4 antigen derivative, glatiramer, HLA antibody, hormone, intercellular adhesion molecule 1 antibody, interleukin 4, peptide derivative, phosphodiesterase inhibitor, vascular cell adhesion molecule 1, cytokine, blood brain barrier, conference paper, cytokine production, desensitization, hormone action, human, immunopathogenesis, immunotherapy, lymphocyte activation, lymphocyte migration, puerperium, vaccination
-
4Academic Journal
المؤلفون: Petrovsky, Nikolai, Silva, Diego, Schatz, Desmond
المصدر: Paediatric Drugs
مصطلحات موضوعية: Keywords: BCG vaccine, diapep, gamma interferon antibody, glutamate decarboxylase, heat shock protein, insulin, intercellular adhesion molecule 1 antibody, interleukin 1 antibody, lymphocyte function associated antigen 1, monoclonal antibody CD3, proinsulin, tumor
Relation: http://hdl.handle.net/1885/76802
-
5
مصطلحات موضوعية: Autoimmunity, Immunology, Lymphocytes, Multiple sclerosis, Pregnancy, alpha interferon, antibody, beta1 integrin, CD4 antigen derivative, glatiramer, HLA antibody, hormone, intercellular adhesion molecule 1 antibody, interleukin 4, peptide derivative, phosphodiesterase inhibitor, vascular cell adhesion molecule 1, cytokine, blood brain barrier, conference paper, cytokine production, desensitization, hormone action, human, immunopathogenesis, immunotherapy, lymphocyte activation, lymphocyte migration, puerperium, vaccination
Relation: https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_02100010_v31_n5_p471_Correale; http://hdl.handle.net/20.500.12110/paper_02100010_v31_n5_p471_Correale
-
6Electronic Resource
المؤلفون: Chadban S.J., Atkins R.C.
مصطلحات الفهرس: glomerulonephritis/dt [Drug Therapy], glomerulonephritis/ep [Epidemiology], glomerulonephritis/et [Etiology], glomerulonephritis/su [Surgery], glomerulonephritis/th [Therapy], glomerulosclerosis/dt [Drug Therapy], glomerulus filtration rate, Goodpasture syndrome/th [Therapy], hematuria, Heymann nephritis, human, hyperlipidemia/dt [Drug Therapy], immune system, immunoglobulin A nephropathy/dt [Drug Therapy], immunosuppressive treatment, infection/si [Side Effect], infection risk, infection sensitivity, inflammation, kidney biopsy, kidney cell, kidney disease, kidney failure/dt [Drug Therapy], cyclophosphamide/po [Oral Drug Administration], kidney transplantation, leukocyte, lung hemorrhage, lupus erythematosus nephritis/dt [Drug Therapy], membranoproliferative glomerulonephritis/dt [Drug Therapy], membranous glomerulonephritis/dt [Drug Therapy], minimal change glomerulonephritis/dt [Drug Therapy], nephrotic syndrome, nonhuman, pathogenesis, plasmapheresis, priority journal, protein restriction, proteinuria/si [Side Effect], rapidly progressive glomerulonephritis/dt [Drug Therapy], rapidly progressive glomerulonephritis/th [Therapy], risk assessment, sex ratio, side effect/si [Side Effect], T cell depletion, treatment outcome, vasculitis/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], antibody/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], hirudin/dt [Drug Therapy], hirudin/pd [Pharmacology], imatinib/dt [Drug Therapy], imatinib/pd [Pharmacology], immunosuppressive agent/ae [Adverse Drug Reaction], immunosuppressive agent/dt [Drug Therapy], immunosuppressive agent/iv [Intravenous Drug Administration], antibody/pd [Pharmacology], antilipemic agent/dt [Drug Therapy], azathioprine/ae [Adverse Drug Reaction], azathioprine/dt [Drug Therapy], azathioprine/po [Oral Drug Administration], azathioprine/pd [Pharmacology], CD20 antibody/dt [Drug Therapy], chlorambucil/ae [Adverse Drug Reaction], chlorambucil/dt [Drug Therapy], chlorambucil/po [Oral Drug Administration], chlorambucil/pd [Pharmacology], corticosteroid/ae [Adverse Drug Reaction], corticosteroid/dt [Drug Therapy], corticosteroid/pd [Pharmacology], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], immunosuppressive agent/po [Oral Drug Administration], immunosuppressive agent/pd [Pharmacology], intercellular adhesion molecule 1 antibody/dt [Drug Therapy], intercellular adhesion molecule 1 antibody/pd [Pharmacology], interleukin 1 receptor blocking agent/dt [Drug Therapy], interleukin 1 receptor blocking agent/pd [Pharmacology], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], mycophenolic acid 2 morpholinoethyl ester/ae [Adverse Drug Reaction], mycophenolic acid 2 morpholinoethyl ester/dt [Drug Therapy], mycophenolic acid 2 morpholinoethyl ester/pd [Pharmacology], n(g) nitroarginine methyl ester/dt [Drug Therapy], n(g) nitroarginine methyl ester/pd [Pharmacology], nitric oxide synthase inhibitor/dt [Drug Therapy], nitric oxide synthase inhibitor/pd [Pharmacology], oligonucleotide/dt [Drug Therapy], oligonucleotide/pd [Pharmacology], prednisone/do [Drug Dose], prednisone/dt [Drug Therapy], prednisone/po [Oral Drug Administration], rapamycin/ae [Adverse Drug Reaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], steroid/dt [Drug Therapy], thrombin inhibitor/dt [Drug Therapy], thrombin inhibitor/pd [Pharmacology], unclassified drug, colony stimulating factor receptor antibody/dt [Drug Therapy], colony stimulating factor receptor antibody/pd [Pharmacology], monocyte chemotactic protein 1 antibody/dt [Drug Therapy], monocyte chemotactic protein 1 antibody/pd [Pharmacology], kidney failure/pc [Prevention], cyclophosphamide/pd [Pharmacology], cyclosporin/dt [Drug Therapy], acute kidney failure/si [Side Effect], Alport syndrome, antibody dependent cellular cytotoxicity, blood clotting, cancer susceptibility, cellular immunity, chronic glomerulonephritis, complement system, conference paper, diagnostic procedure, disease association, drug efficacy, drug induced cancer/si [Side Effect], drug safety, Conference Paper
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/27330
The Lancet
Click here for full text options
LibKey Link -
7Electronic Resource
المؤلفون: Tipping P.G., Holdsworth S.R., Huang X.R.
مصطلحات الفهرس: rat, T lymphocyte, intercellular adhesion molecule 1 antibody, OKT 4, animal tissue, cell proliferation, animal experiment, animal model, article, controlled study, giant cell, glomerulonephritis/et [Etiology], helper cell, immunohistochemistry, macrophage, male, monocyte, nonhuman, phenotype, priority journal, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/33765
Click here for full text options
LibKey Link -
8Electronic Resource
المؤلفون: Looareesuwan S., Kubes P., Yipp B.G., Hickey M.J., Ho M., Andonegui G., Murray A.G.
مصطلحات الفهرس: Plasmodium falciparum, priority journal, protein interaction, SCID mouse, skin graft, vascular endothelium, CD36 antigen/ec [Endogenous Compound], histamine, intercellular adhesion molecule 1/ec [Endogenous Compound], intercellular adhesion molecule 1 antibody, PADGEM protein/ec [Endogenous Compound], protein antibody, tumor necrosis factor alpha, vascular cell adhesion molecule 1/ec [Endogenous Compound], cell count, adult, animal cell, animal experiment, animal tissue, article, cell adhesion, controlled study, erythrocyte adhesiveness, experimental model, human, human cell, human tissue, in vitro study, in vivo study, malaria falciparum/et [Etiology], microvasculature, mouse, nonhuman, pathogenesis, Article
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/31784
Click here for full text options
LibKey Link -
9Electronic Resource
المؤلفون: Tesch G.H., Nikolic-Paterson D.J., Lan H.Y.
مصطلحات الفهرس: chemokine/ec [Endogenous Compound], colony stimulating factor 1/ec [Endogenous Compound], endothelin 1/ec [Endogenous Compound], fibroblast growth factor/ec [Endogenous Compound], gamma interferon, growth factor/ec [Endogenous Compound], Hermes antigen/ec [Endogenous Compound], intercellular adhesion molecule 1/ec [Endogenous Compound], intercellular adhesion molecule 1 antibody/ec [Endogenous Compound], interleukin 1/ec [Endogenous Compound], lipopolysaccharide, low density lipoprotein, macrophage migration inhibition factor/ec [Endogenous Compound], messenger RNA/ec [Endogenous Compound], monoclonal antibody, monocyte chemotactic protein 1/ec [Endogenous Compound], neutralizing antibody/ec [Endogenous Compound], platelet derived growth factor/ec [Endogenous Compound], protein/ec [Endogenous Compound], proteoglycan/ec [Endogenous Compound], somatomedin C/ec [Endogenous Compound], tumor necrosis factor alpha, vascular cell adhesion molecule 1/ec [Endogenous Compound], selectin/ec [Endogenous Compound], cell adhesion, cell growth, cell proliferation, glomerulosclerosis/et [Etiology], human, kidney failure, macrophage, mesangium cell, nonhuman, priority journal, review, antibody, basic fibroblast growth factor/ec [Endogenous Compound], CD11 antigen/ec [Endogenous Compound], CD18 antigen/ec [Endogenous Compound], Review
URL:
https://repository.monashhealth.org/monashhealthjspui/handle/1/33488
Nephrology
Click here for full text options
LibKey Link